We recently published a list of 13 Stocks on Jim Cramer’s Radar Recently. In this article, we are going to take a look at ...

Pfizer's 7.45% dividend yield can't offset weak growth, declining EPS, and patent risks. Read more on PFE and why analysts ...

Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands ...

Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...

Europe's second-top court on Wednesday dismissed the European Commission's rejection of a New York Times' request to access text messages between its President Ursula von der Leyen and Pfizer CEO ...

Income investors have liked Pfizer (NYSE: PFE) for years. However, the big drugmaker's exceptionally juicy dividend these ...

The company disclosed revenue of $13.7 billion and adjusted earnings of $0.92 per share, compared to consensus estimates of $14.1 billion and $0.68, respectively.

The executive order that Donald Trump has signed over the last 24 hours could have a significant effect on pharmaceutical ...

Pfizer's robust product pipeline and consistent R&D investments position it well for future growth. See why I rate PFE stock a strong buy ahead of earnings.

NEW YORK, April 29, 2025--Pfizer Inc. (NYSE: PFE) reported financial results for the first quarter of 2025 and reaffirmed its 2025 financial guidance(1). NEW YORK, April 26, 2025--Pfizer Inc ...

In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other best high-yield dividend stocks. Over the years, dividend-paying stocks have become increasingly ...

We recently published a list of 13 Stock Predictions That Jim Cramer Got Completely Wrong. In this article, we are going to ...